Clinical Studies and Clinical Indications. BGM use Commercially Reasonable Efforts to perform the following activities in support of Galectin-3 clinical development. These activities shall be reviewed at the quarterly Steering Committee meetings and adjusted by mutual written agreement of the Parties.
Appears in 6 contracts
Samples: Galectin 3 License and Distribution Agreement (BG Medicine, Inc.), Galectin 3 License and Distribution Agreement (BG Medicine, Inc.), Galectin 3 License and Distribution Agreement (BG Medicine, Inc.)